These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 573873)

  • 1. Hyperactivity induced by injection of dopamine into the accumbens nucleus: actions and interactions of neuroleptic, cholinomimetic and cholinolytic agents.
    Costall B; Hui SC; Naylor RJ
    Neuropharmacology; 1979; 18(8-9):661-5. PubMed ID: 573873
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens.
    Pycock CJ; Horton RW
    J Neural Transm; 1979; 45(1):17-33. PubMed ID: 112217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulpiride injected into the dorsal striatum and the nucleus accumbens on dopamine-mediated oral stereotypy and hyperlocomotion in rats.
    Koshikawa N; Aoki S; Imai E; Kobayashi M
    J Nihon Univ Sch Dent; 1986 Jun; 28(2):109-16. PubMed ID: 3463674
    [No Abstract]   [Full Text] [Related]  

  • 5. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
    Cools AR; Oosterloo SK
    J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist.
    Patel S; Slater P; Crossman AR
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):334-40. PubMed ID: 4094623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Y-516 on the hyperactivity induced by dopamine injected bilaterally into the nucleus accumbens].
    Morimoto T; Morimoto Y; Fukuda T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):65-71. PubMed ID: 2227720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.
    de Belleroche JS; Gardiner IM
    Br J Pharmacol; 1982 Feb; 75(2):359-65. PubMed ID: 7186823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW; Nemeroff CB; Prange AJ
    Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1978 Apr; 30(4):257-9. PubMed ID: 24720
    [No Abstract]   [Full Text] [Related]  

  • 11. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior.
    Kalivas PW; Miller JS
    Biochem Pharmacol; 1985 Jan; 34(2):284-6. PubMed ID: 3966931
    [No Abstract]   [Full Text] [Related]  

  • 13. Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the rat.
    de Belleroche JS; Winn P; Murzi E; Williams SF; Herberg LJ
    J Neural Transm; 1982; 54(3-4):134-43. PubMed ID: 6813423
    [No Abstract]   [Full Text] [Related]  

  • 14. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of haloperidol and sulpiride on dopamine-induced inhibition of nucleus accumbens neurons.
    Akaike A; Sasa M; Takaori S
    Life Sci; 1983 Jun; 32(23):2649-53. PubMed ID: 6855460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of cholecystokinin and dopamine in the nucleus accumbens.
    Wang RY; White FJ; Voigt MM
    Ann N Y Acad Sci; 1985; 448():352-60. PubMed ID: 2862829
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
    Watling KJ; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats.
    Pulvirenti L; Swerdlow NR; Koob GF
    Neurosci Lett; 1989 Aug; 103(2):213-8. PubMed ID: 2771183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC; Uretsky NJ
    Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.